Science
Mechanism of Action
The specific mechanism of action for TRANSGENIC SILKWORM RH-POLYPEPTIDE-47 within the skin is not detailed in readily available research. While polypeptides typically interact with cellular receptors to modulate biological processes like cell proliferation or extracellular matrix synthesis, the exact pathways for this specific molecule remain uncharacterized.
Research
Clinical Evidence
Insufficient-data confidenceN/A
Transparency
Dusting Analysis
With no public clinical or market usage data, it is not possible to assess if TRANSGENIC SILKWORM RH-POLYPEPTIDE-47 is commonly 'dusted' or used at concentrations below efficacy thresholds. Its novel nature suggests it is not yet widely adopted in consumer products.
The Formula
Formulation
Stability
Specific pH stability, solubility characteristics, and general formulation compatibility data are not publicly available for TRANSGENIC SILKWORM RH-POLYPEPTIDE-47.
Safety
Safety Profile
Comprehensive safety assessments, including those from regulatory bodies like CIR, SCCS, or FDA, are not present in the provided research data. Without this, specific risk profiles for irritation, sensitization, or use during pregnancy remain uncharacterized.
Your Skin
Skin Compatibility
Our Assessment
Verdict
Due to a complete absence of public research data, clinical studies, safety assessments, and formulation guidelines, the efficacy and safety of TRANSGENIC SILKWORM RH-POLYPEPTIDE-47 cannot be evaluated at this time.
Related
Similar Ingredients
Finding similar ingredients…